Wholomics
Wholomics provides a quick, minimally-invasive liquid biopsy for early cancer detection that can be used in routine screening. It uses a multi-omics approach powered by AI to identify cancer-specific molecular signals in blood. The product is delivered as a SaaS solution for healthcare professionals and patients. Validated milestones include detecting pancreatic cancer at Stage I and presenting studies at ASCO conferences. The company operates in oncology diagnostics with broad potential to scale across healthcare systems in Europe.
Wholomics
Wholomics provides a quick, minimally-invasive liquid biopsy for early cancer detection that can be used in routine screening. It uses a multi-omics approach powered by AI to identify cancer-specific molecular signals in blood. The product is delivered as a SaaS solution for healthcare professionals and patients. Validated milestones include detecting pancreatic cancer at Stage I and presenting studies at ASCO conferences. The company operates in oncology diagnostics with broad potential to scale across healthcare systems in Europe.